Matthijs van Leeuwen - Chief Operating Officer

Matthijs is SimuGen's co-founder and is responsible for the company's operational and business development activities.

In addition to his UK and Singaporean entrepreneurial activities, Matthijs has been very active as a consultant at the Cambridge-MIT Institute and Library House in Cambridge. Most recently he was a biotech analyst at London-based Imperial Innovations, one of Europe's leading technology commercialisation and investment companies.

Matthijs holds a B.Sc. in Biomedical Sciences and M.Sc. in Science & Business from the University of Utrecht, and gained research experience at the University of Cambridge.